Discovery of the cancer stem cell related determinants of radioresistance

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 378-387

  Peitzsch, Claudia ^a   Kurth, Ina ^a   Kunz Schughart, Leoni ^a   Baumann, Michael ^a,b   Dubrovska, Anna ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Biomarkers; Cancer stem cells; Microenvironment; Radioresistance

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ALPHA6 INTEGRIN; ANTINEOPLASTIC AGENT; BETA CATENIN; BIOLOGICAL MARKER; CD133 ANTIGEN; CD24 ANTIGEN; CYTOKINE; DNA; GLYCOPROTEIN; GROWTH FACTOR; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR; INTERLEUKIN DERIVATIVE; MEMBRANE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMAD3 PROTEIN; STAT3 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; WNT PROTEIN;

AEROBIC METABOLISM; CANCER CELL; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STEM CELL; CANCER THERAPY; CELL ADHESION; CELL CYCLE ARREST; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL HYPOXIA; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; DNA DAMAGE; DNA MICROARRAY; ENDOCYTOSIS; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IONIZING RADIATION; MASS SPECTROMETRY; ONCOGENE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TARGET CELL;

BIOMARKERS; CANCER STEM CELLS; MICROENVIRONMENT; RADIORESISTANCE;

ANIMALS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; TUMOR MICROENVIRONMENT;

EID: 84887019122     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.003     Document Type: Review

References (164)

1. L.V. Nguyen, R. Vanner, P. Dirks, and C.J. Eaves Cancer stem cells: an evolving concept Nat Rev Cancer 12 2012 133 143
2. I. Baccelli, and A. Trumpp The evolving concept of cancer and metastasis stem cells J Cell Biol 198 2012 281 293
3. T.B. Brunner, L.A. Kunz-Schughart, P. Grosse-Gehling, and M. Baumann Cancer stem cells as a predictive factor in radiotherapy Semin Radiat Oncol 22 2012 151 174
4. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554
5. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, and J. Caceres-Cortes A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648
6. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
7. H. Suit, and R. Wette Radiation dose fractionation and tumor control probability Radiat Res 29 1966 267 281
8. R.P. Hill, and L. Milas The proportion of stem cells in murine tumors Int J Radiat Oncol Biol Phys 16 1989 513 518
9. M. Baumann, W. Dubois, and H.D. Suit Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units Radiat Res 123 1990 325 330
10. H.H. Dubben, H.D. Thames, and H.P. Beck-Bornholdt Tumor volume: a basic and specific response predictor in radiotherapy Radiother Oncol 47 1998 167 174
11. J. Ramsay, R. Ward, and N.M. Bleehen Radiosensitivity testing of human malignant gliomas Int J Radiat Oncol Biol Phys 24 1992 675 680
12. C.M. West, S.E. Davidson, S.A. Roberts, and R.D. Hunter Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix Br J Cancer 68 1993 819 823
13. T. Girinsky, R. Lubin, J.P. Pignon, N. Chavaudra, J. Gazeau, and B. Dubray Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival Int J Radiat Oncol Biol Phys 25 1993 3 7
14. W.A. Brock, F.L. Baker, J.L. Wike, S.L. Sivon, and L.J. Peters Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control Int J Radiat Oncol Biol Phys 18 1990 1283 1286
15. M.J. Allalunis-Turner, G.M. Barron, R.S. Day 3rd, D.S. Fulton, and R.C. Urtasun Radiosensitivity testing of human primary brain tumor specimens Int J Radiat Oncol Biol Phys 23 1992 339 343
16. A. Taghian, J. Ramsay, J. Allalunis-Turner, W. Budach, D. Gioioso, and F. Pardo Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme Int J Radiat Oncol Biol Phys 25 1993 243 249
17. F. Eschwege, J. Bourhis, T. Girinski, E. Lartigau, M. Guichard, and D. Deblé Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience Int J Radiat Oncol Biol Phys 39 1997 849 853
18. B. Stausbøl-Grøn, and J. Overgaard Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck Radiother Oncol 50 1999 47 55
19. R.R. Weichselbaum, M.A. Beckett, W. Dahlberg, and A. Dritschilo Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones Int J Radiat Oncol Biol Phys 14 1988 907 912
20. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, and T. Hoey The prognostic role of a gene signature from tumorigenic breast-cancer cells NEJM 356 2007 217 226
21. Y.C. Chen, Y.W. Chen, H.S. Hsu, L.M. Tseng, P.I. Huang, and K.H. Lu Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer Biochem Biophys Res Commun 385 2009 307 313
22. J. Mihatsch, M. Toulany, P.M. Bareiss, S. Grimm, C. Lengerke, and R. Kehlbach Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro Radiother Oncol 99 2011 300 306
23. S. Facchino, M. Abdouh, W. Chatoo, and G. Bernier BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery J Neurosci 30 2010 10096 10111
24. C.L. Nilsson, R. Dillon, A. Devakumar, S.D. Shi, M. Greig, and J.C. Rogers Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells J Proteome Res 9 2010 430 443
25. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, and D. Peck MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
26. Y. Shimono, M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, and D. Qian Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 2009 592 603
27. D. Yan, W.L. Ng, X. Zhang, P. Wang, Z. Zhang, and Y.Y. Mo Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation PLoS One 5 2010 e11397
28. C. Qu, Z. Liang, J. Huang, R. Zhao, C. Su, and S. Wang MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN Cell Cycle 11 2012 785 796
29. S. Grosso, J. Doyen, S.K. Parks, T. Bertero, A. Paye, and B. Cardinaud MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines Cell Death Dis 4 2013 e544
30. M. Svoboda, J. Sana, P. Fabian, I. Kocakova, J. Gombosova, and J. Nekvindova MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients Radiat Oncol 7 2012 195
31. W.Y. Mansour, N.V. Bogdanova, U. Kasten-Pisula, T. Rieckmann, S. Köcher, and K. Borgmann Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma Radiother Oncol 106 2013 147 154
32. C.R. Schoof, E.L. Botelho, A. Izzotti, and R. Vasques Ldos MicroRNAs in cancer treatment and prognosis Am J Cancer Res 2 2012 414 433
33. L. Ding, I. Poser, M. Paszkowski-Rogacz, and F. Buchholz From RNAi screens to molecular function in embryonic stem cells Stem Cell Rev 8 2012 Mar 32 42
34. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, and R.A. Weinberg Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 2009 645 659
35. B.E. Lally, G.A. Geiger, S. Kridel, A.E. Arcury-Quandt, M.E. Robbins, and N.D. Kock Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library Cancer Res 67 2007 8791 8799
36. M. Zheng, S.E. Morgan-Lappe, J. Yang, K.M. Bockbrader, D. Pamarthy, and D. Thomas Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2 Cancer Res 68 2008 7570 7578
37. S. Fu, Y. Yang, D. Tirtha, Y. Yen, B.S. Zhou, and M.M. Zhou γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers PLoS One 7 2012 e38465
38. E. Sachlos, R.M. Risueño, S. Laronde, Z. Shapovalova, J.H. Lee, and J. Russell Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells Cell 149 2012 1284 1297
39. C.R. Jeter, B. Liu, X. Liu, X. Chen, C. Liu, and T. Calhoun-Davis NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation Oncogene 30 2011 3833 3845
40. B.H. Yoo, S.D. Axlund, P. Kabos, B.G. Reid, J. Schaack, and C.A. Sartorius A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer J Biomol Screen 17 2012 1211 1220
41. L. Della Donna, C. Lagadec, and F. Pajonk Radioresistance of prostate cancer cells with low proteasome activity Prostate 72 2011 868 874
42. E. Vlashi, K. Kim, C. Lagadec, L.D. Donna, J.T. McDonald, and M. Eghbali In vivo imaging, tracking, and targeting of cancer stem cells J Natl Cancer Inst 101 2009 350 359
43. X. Xia, J. Yang, F. Li, Y. Li, X. Zhou, and Y. Dai Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells Cancer Res 70 2010 7723 7733
44. H. Wurdak, S. Zhu, A. Romero, M. Lorger, J. Watson, and C.Y. Chiang An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation Cell Stem Cell 6 2010 37 47
45. S. Pece, D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi, and S. Ronzoni Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell 140 2010 62 73
46. W.J. Wang, S.P. Wu, J.B. Liu, Y.S. Shi, X. Huang, and Q.B. Zhang MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells Cancer Res 73 2013 1219 1231
47. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, and M.J. Kawamura In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270
48. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, and D. Coradini Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506 5511
49. K.M. Yamada, and E. Cukierman Modeling tissue morphogenesis and cancer in 3D Cell 130 2007 601 610
50. J.D. Schwartz, E.K. Rowinsky, H. Youssoufian, B. Pytowski, and Y. Wu Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (human antibody targeting vascular endothelial growth factor receptor-1) Cancer 116 2010 1027 1032
51. J. Friedrich, R. Ebner, and L.A. Kunz-Schughart Experimental anti-tumor therapy in 3-D: spheroids - old hat or new challenge? Int J Radiat Biol 83 2007 849 871
52. I. Eke, and N. Cordes Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation Radiother Oncol 99 2011 271 278
53. K. Visnyei, H. Onodera, R. Damoiseaux, K. Saigusa, S. Petrosyan, and D. De Vries A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells Mol Cancer Ther 10 2011 1818 1828
54. P. Diamandis, J. Wildenhain, I.D. Clarke, A.G. Sacher, J. Graham, and D.S. Bellows Chemical genetics reveals a complex functional ground state of neural stem cells Nat Chem Biol 3 2007 268 273
55. T. Graf, and M. Stadtfeld Heterogeneity of embryonic and adult stem cells Cell Stem Cell 3 2008 480 483
56. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 2012 306 313
57. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 2009 265 273
58. M. Shibata, and M.M. Shen The roots of cancer: stem cells and the basis for tumor heterogeneity BioEssays 35 2012 253 260
59. A.B. Hjelmeland, and J.N. Rich The quest for self-identity: not all cancer stem cells are the same Clin Cancer Res 18 2012 3495 3498
60. S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, and A.B. Hjelmeland Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
61. M. Ropolo, A. Daga, F. Griffero, M. Foresta, G. Casartelli, and A. Zunino Comparative analysis of DNA repair in stem and nonstem glioma cell cultures Mol Cancer Res 7 2009 383 392
62. J.M. Stewart, P.A. Shaw, C. Gedye, M.Q. Bernardini, B.G. Neel, and L.E. Ailles Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells Proc Natl Acad Sci U S A 108 2011 6468 6473
63. N. Navin, J. Kendall, J. Troge, P. Andrews, L. Rodgers, and J. McIndoo Tumour evolution inferred by single-cell sequencing Nature 472 2011 90 94
64. A. Sottoriva, I. Spiteri, D. Shibata, C. Curtis, and S. Tavare Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization Cancer Res 73 2013 41 49
65. W.W. Hwang-Verslues, W.H. Kuo, P.H. Chang, C.C. Pan, and H.H. Wang Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers PLoS One 4 2009 e8377
66. D.G. Tang Understanding cancer stem cell heterogeneity and plasticity Cell Res 22 2012 457 472
67. A. Kreso, C.A. O'Brien, P. van Galen, O.I. Gan, F. Notta, and A.M. Brown Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer Science 339 2013 543 548
68. R. Bütof, and M. Baumann Time in radiation oncology - keep it short! Radiother Oncol 106 2013 271 275
69. F. Pajonk, E. Vlashi, and W.H. McBride Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited Stem Cells 28 2010 639 648
70. D.H. Nguyen, H.A. Oketch-Rabah, I. Illa-Bochaca, F.C. Geyer, J.S. Reis-Filho, and J.H. Mao Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type Cancer Cell 19 2011 640 651
71. I. Sofia Vala, L.R. Martins, N. Imaizumi, R.J. Nunes, J. Rino, and F. Kuonen Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis PLoS One 5 2010 e11222
72. F. Kuonen, C. Secondini, and C. Ruegg Molecular pathways: emerging pathways mediating growth, invasion and metastasis of tumors progressing in an irradiated microenvironment Clin Cancer Res 18 2012 1 7
73. M. Baumann, T. Herrmann, R. Koch, W. Matthiessen, S. Appold, and B. Wahlers Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
74. Y. Tao, N. Daly-Schveitzer, A. Lusinchi, and J. Bourhis Advances in radiotherapy of head and neck cancers Curr Opin Oncol 22 2010 194 199
75. P.B. Gupta, C.M. Fillmore, G. Jiang, S.D. Shapira, K. Tao, and C. Kuperwasser Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells Cell 146 2011 633 644
76. S.M. Kumar, S. Liu, H. Lu, H. Zhang, P.J. Zhang, and P.A. Gimotty Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation Oncogene 31 2012 4898 4911
77. Z. Liu, Q. Li, K. Li, L. Chen, W. Li, and M. Hou Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells Oncogene 2012 10.1038/onc.2012.441
78. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, and A.Y. Zhou The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
79. M.K. Asiedu, J.N. Ingle, M.D. Behrens, D.C. Radisky, and K.L. Knutson TGFβ/TNFα-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype Cancer Res 71 2011 4707 4719
80. D. Iliopoulos, H.A. Hirsch, G. Wang, and K. Struhl Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc Natl Acad Sci U S A 108 2011 1397 1402
81. Y. Li, L. Wang, L. Pappan, A. Galliher-Beckley, and J. Shi IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation Mol Cancer 11 2012 87
82. C.H. Yoon, M.J. Kim, H. Lee, R.K. Kim, E.J. Lim, and K.C. Yoo PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population J Biol Chem 287 2012 19516 19527
83. D.T. Scadden The stem-cell niche as an entity of action Nature 441 2006 1075 1079
84. I. Malanchi, A. Santamaria-Martínez, E. Susanto, H. Peng, H.A. Lehr, and J.F. Delaloye Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 2011 85 89
85. J.M. Heddleston, Z. Li, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
86. A.B. Hjelmeland, J.D. Lathia, S. Sathornsumetee, and J.N. Rich Twisted tango: brain tumor neurovascular interactions Nat Neurosci 14 2011 1375 1381
87. S.W. Lane, Y.J. Wang, C. Lo Celso, C. Ragu, L. Bullinger, and S.M. Sykes Differential niche and Wnt requirements during acute myeloid leukemia progression Blood 118 2011 2849 2856
88. M.T. Shekhani, A.S. Jayanthy, N. Maddodi, and V. Setaluri Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies Am J Stem Cells 2 2013 52 61
89. T. Borovski, De Sousa E. Melo, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res 71 2011 634 639
90. M.L. Burness, and D.A. Sipkins The stem cell niche in health and malignancy Semin Cancer Biol 20 2010 107 115
91. J.D. Lathia, J.M. Heddleston, M. Venere, and J.N. Rich Deadly teamwork: neural cancer stem cells and the tumor microenvironment Cell Stem Cell 8 2011 482 485
92. J.S. Hale, M. Li, and J.D. Lathia The malignant social network: cell-cell adhesion and communication in cancer stem cells Cell Adh Migr 6 2012 346 355
93. A. Filatova, T. Acker, and B.K. Garvalov The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment Biochim Biophys Acta 1830 2013 2496 2508
94. N. Charles, and E.C. Holland The perivascular niche microenvironment in brain tumor progression Cell Cycle 9 2010 3012 3021
95. A. Pietras, D. Gisselsson, I. Ora, R. Noguera, S. Beckman, and S. Navarro High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche J Pathol 214 2008 482 488
96. C. Calabrese, H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, and B. Hamner A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
97. J.M. Heddleston, M. Hitomi, M. Venere, W.A. Flavahan, K. Yang, and Y. Kim Glioma stem cell maintenance: the role of the microenvironment Curr Pharm 17 2011 2386 2401
98. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin Cancer Biol 22 2012 396 403
99. N. Tiwari, A. Gheldof, M. Tatari, and G. Christofori EMT as the ultimate survival mechanism of cancer cells Semin Cancer Biol 22 2012 194 207
100. J.P. Sleeman, G. Christofori, R. Fodde, J.G. Collard, G. Berx, and C. Decraene Concepts of metastasis in flux: the stromal progression model Semin Cancer Biol 22 2012 174 186
101. S. Brabletz, O. Schmalhofer, and T. Brabletz Gastrointestinal stem cells in development and cancer J Pathol 217 2009 307 317
102. A. Mohyeldin, T. Garzon-Muvdi, and A. Quinones-Hinojosa Oxygen in stem cell biology: a critical component of the stem cell niche Cell Stem Cell 7 2010 150 161
103. J.M. Heddleston, Q. Wu, and M. Rivera Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential Cell Death Differ 19 2012 428 439
104. B. Bao, A.S. Azmi, S. Ali, A. Ahmad, Y. Li, and S. Banerjee The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness Biochim Biophys Acta 1826 2012 272 296
105. L. Qiang, T. Wu, H.W. Zhang, N. Lu, R. Hu, and Y.J. Wang HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating notch signaling pathway Cell Death Differ 19 2012 284 294
106. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, and C.M. Pinna HIF induces human embryonic stem cell markers in cancer cells Cancer Res 71 2011 4640 4652
107. R. McCormick, F.M. Buffa, J. Ragoussis, and A.L. Harris The role of hypoxia regulated microRNAs in cancer Curr Top Microbiol Immunol 345 2010 47 70
108. J.K. Smit, H. Faber, M. Niemantsverdriet, M. Baanstra, J. Bussink, and H. Hollema Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers Radiother Oncol. 107 2013 434 441
109. J. Theys, B. Jutten, R. Habets, K. Paesmans, A.J. Groot, and P. Lambin E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells Radiother Oncol 99 2011 392 397
110. P. Gao, L. Sun, X. He, Y. Cao, and H. Zhang MicroRNAs and the Warburg effect: new players in an old arena Curr Gene Ther 12 2012 285 291
111. J.A. Menendez, J. Joven, S. Cufí, B. Corominas-Faja, C. Oliveras-Ferraros, and E. Cuyàs The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells Cell Cycle 12 2013 1166 1179
112. C. Jose, N. Bellance, and R. Rossignol Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807 2011 552 561
113. K. Smolkova, L. Plecita-Hlavata, N. Bellance, G. Benard, R. Rossignol, and P. Jezek Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells Int J Biochem Cell Biol 43 2011 950 968
114. M.V. Berridge, P.M. Herst, and A.S. Tan Metabolic flexibility and cell hierarchy in metastatic cancer Mitochondrion 10 2010 584 588
115. G. Bonuccelli, A. Tsirigos, D. Whitaker-Menezes, S. Pavlides, R.G. Pestell, and B. Chiavarina Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism Cell Cycle 9 2010 3506 3514
116. F. Hirschhaeuser, U.G. Sattler, and W. Mueller-Klieser Lactate: a metabolic key player in cancer Cancer Res 71 2011 6921 6925
117. P.E. Porporato, S. Dhup, R.K. Dadhich, T. Copetti, and P. Sonveaux Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review Front Pharmacol 2 2011 49
118. M.G. Vander Heiden Targeting cancer metabolism: a therapeutic window opens Nat Rev Drug Discov 10 2011 671 684
119. S.K. Singh, I.D. Clarke, M. Terasaki, V.E. Bonn, C. Hawkins, and J. Squire Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821 5828
120. X. Yuan, J. Curtin, Y. Xiong, G. Liu, S. Waschsmann-Hogiu, and D.L. Farkas Isolation of cancer stem cells from adult glioblastoma multiforme Oncogene 23 2004 9392 9400
121. M.J. Son, K. Woolard, D.H. Nam, J. Lee, and H.A. Fine SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma Cell Stem Cell 4 2009 440 452
122. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, and S.G. Kernie A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
123. J.D. Lathia, J. Gallagher, J.M. Heddleston, J. Wang, C.E. Eyler, and J. Macswords Integrin alpha 6 regulates glioblastoma stem cells Cell Stem Cell 6 2010 421 432
124. M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, and L. Varticovski Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res 10 2008 R10
125. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
126. M.J. Meyer, J.M. Fleming, A.F. Lin, S.A. Hussnain, E. Ginsburg, and B.K. Vonderhaar CD44pos CD49f hi CD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer Cancer Res 70 2010 4624 4633
127. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
128. L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, and C. Peschle Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
129. E.H. Huang, M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, and H. Appelman Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res 69 2009 3382 3389
130. P. Chu, D.J. Clanton, T.S. Snipas, J. Lee, E. Mitchell, and M.L. Nguyen Characterization of a subpopulation of colon cancer cells with stem cell-like properties Int J Cancer 124 2009 1312 1321
131. N. Haraguchi, H. Ishii, K. Mimori, K. Ohta, M. Uemura, and J. Nishimura CD49f-positive cell population efficiently enriches colon cancer-initiating cells Int J Oncol. 43 2013 425 430
132. M.E. Prince, R. Sivanandan, A. Kaczorowski, G.T. Wolf, M.J. Kaplan, and P. Dalerba Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
133. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
134. L. Patrawala, T. Calhoun, R. Schneider-Broussard, H. Li, B. Bhatia, and S. Tang Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
135. L. Patrawala, T. Calhoun-Davis, R. Schneider-Broussard, and D.G. Tang Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells Cancer Res 67 2007 6796 6805
136. T. Li, Y. Su, Y. Mei, Q. Leng, B. Leng, and Z. Liu ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome Lab Invest 90 2010 234 244
137. Y. Wei, Y. Jiang, F. Zou, Y. Liu, S. Wang, and N. Xu Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells Proc Natl Acad Sci U S A. 110 2013 6829 6834
138. E. Bourseau-Guilmain, A. Griveau, J.P. Benoit, and E. Garcion The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells PLoS One 6 2011 e25515
139. A. Adini, I. Adini, K. Ghosh, O. Benny, E. Pravda, and R. Hu The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action Angiogenesis 16 2013 405 416
140. P. Grosse-Gehling, C.A. Fargeas, C. Dittfeld, Y. Garbe, M.R. Alison, and D. Corbeil CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges J Pathol 229 2013 355 378
141. Su Ying-Jhen, Hsin-Mei Lai, Yi-Wen Chang, Guan-Ying Chen, and Jia-Lin Lee Direct reprogramming of stem cell properties in colon cancer cells by CD44 EMBO J 30 2011 3186 3199
142. - breast cancer cells Onco Targets Ther 4 2011 71 78
143. S. Misra, P. Heldin, V.C. Hascall, N.K. Karamanos, S.S. Skandalis, and R.R. Markwald HA/CD44 interactions as potential targets for cancer therapy FEBS J 278 2011 1429 1443
144. J.L. Lee, M.J. Wang, and J.Y. Chen Acetylation and activation of STAT3 mediated by nuclear translocation of CD44 J Cell Biol 185 2009 949 957
145. J.Y. So, A.K. Smolarek, D.M. Salerno, H. Maehr, M. Uskokovic, and F. Liu Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer PLoS One 8 2013 e54020
146. I. Ma, and A.L. Allan The role of human aldehyde dehydrogenase in normal and cancer stem cells Stem Cell Rev 7 2011 292 306
147. M. Barczyk, S. Carracedo, and D. Gullberg Integrins Cell Tissue Res 339 2010 269 280
148. H. Schabath, S. Runz, S. Joumaa, and P. Altevogt CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells J Cell Sci 119 2006 314 325
149. N. Bretz, A. Noske, S. Keller, N. Erbe-Hofmann, T. Schlange, and A.V. Salnikov CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion Clin Exp Metastasis 29 2012 27 38
150. J.H. Ju, K. Jang, K.M. Lee, M. Kim, J. Kim, and J.Y. Yi CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells Carcinogenesis 32 2011 1474 1483
151. T.M. Phillips, W.H. McBride, and F. Pajonk The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation J Natl Cancer Inst 98 2006 1777 1785
152. M. Zhang, R.L. Atkinson, and J.M. Rosen Selective targeting of radiation-resistant tumor-initiating cells Proc Natl Acad Sci U S A 107 2007 3522 3527
153. H. Yin, and J. Glass The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling PLoS One 6 2011 e24080
154. M. Diehn, R.W. Cho, N.A. Lobo, T. Kalisky, M.J. Dorie, and A.N. Kulp Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 2009 780 783
155. T. Ishimoto, O. Nagano, T. Yae, M. Tamada, T. Motohara, and H. Oshima CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell 19 2011 387 400
156. J. Wang, T.P. Wakeman, J.D. Lathia, A.B. Hjelmeland, X.F. Wang, and R.R. White Notch promotes radioresistance of glioma stem cells Stem Cells 28 2010 17 28
157. M. Zhang, R.L. Atkinson, and J.M. Rosen Selective targeting of radiation-resistant tumor-initiating cells Proc Natl Acad Sci U S A 107 2010 3522 3527
158. F. Pistollato, E. Rampazzo, L. Persano, S. Abbadi, C. Frasson, and L. Denaro Interaction of hypoxia-inducible factor-1α and notch signaling regulates medulloblastoma precursor proliferation and fate Stem Cells 28 2010 1918 2929
159. F. Pistollato, S. Abbadi, E. Rampazzo, L. Persano, A. Della Puppa, and C. Frasson Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma Stem Cells 28 2010 851 862
160. X.G. Mao, M. Yan, X.Y. Xue, X. Zhang, H.G. Ren, and G. Guo Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors Lab Invest 91 2011 1068 1078
161. M. Jamal, B.H. Rath, P.S. Tsang, K. Camphausen, and P.J. Tofilon The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells Neoplasia 14 2012 150 158
162. M.E. Hardee, A.E. Marciscano, C.M. Medina-Ramirez, D. Zagzag, A. Narayana, and S.M. Lonning Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β Cancer Res 72 2012 4119 4129
163. A. Dubrovska, J. Elliott, R.J. Salamone, G.D. Telegeev, A.E. Stakhovsky, and I.B. Schepotin CXCR4 expression in prostate cancer progenitor cells PLoS One 7 2012 e31226
164. A. Dubrovska, S. Kim, R.J. Salamone, J.R. Walker, S.M. Maira, and C. García-Echeverría The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations Proc Natl Acad Sci U S A 106 2009 268 273